August 6, 2012

PVCT on SeekingAlpha: Yervoy Vs. Zelboraf: Melanoma Drugs Battle For Market Share

An article on SeekingAlpha by Peter Geschek on July 24 contrasted and compared metastic melanoma drugs Yervoy (Bristol Meyers) and Zelboraf (Roche). Towards the end, the author briefly mentions Provectus.

No comments:

Post a Comment